Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Laura on +441494 818 026 or laura@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Laura Marsh
Account Manager
laura@zenopa.com
+441494 818 026

Testimonials
My Account Manager and their team at Zenopa have provided an excellent recruitment service while I was seeking a new position in the pharmaceutical sector.
Lowri, 2013

GlaxoSmithKline announces production alliance with Russian firm

26 November 2010 00:00 in Pharmaceutical Company Product News


GlaxoSmithKline (GSK) has signed an agreement with Russian company JSC Binnopharm over the secondary manufacture of a number of its vaccines.

The alliance will see GSK provide JSC Binnopharm with bulk vaccines, as well as the technology and expertise to enable the local production of cervical cancer, rotavirus and pneumococcal vaccines.

GSK said the deal should help Russia to update its National Immunisation Calendar by providing additional vaccination against common infections.

The agreement, which was signed in Moscow during the session of the Russian-British Intergovernmental Steering Committee (ISC) for Trade and Investment, was endorsed by business secretary Vince Cable.

He said the alliance "emphasises the strong pharmaceutical links that the UK shares with Russia".

Mr Cable added: "Not only does this demonstrate trust between companies sharing their knowledge across borders, but ordinary people will see the benefits."

JSC Binnopharm will be responsible for gaining approval for the supply of GSK vaccines to the Russian public market.

Earlier this month, GSK extended its collaborative agreement with Fiocruz of Brazil to research and develop new medicines for tropical diseases.ADNFCR-8000103-ID-800257951-ADNFCR

Other news stories from 26/11/2010

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd